Revolution Medicines
The Senior Manager, Commercial Training serves as a strategic leader within the Commercial Excellence organization, optimizing training across multiple therapeutic areas to enable high-quality, compliant customer engagement in Japan. This role develops and oversees an integrated training and capability development strategy for the sales and commercial organizations, ensuring alignment with business objectives and upcoming product launch strategies. The position reports to the Head of Commercial Excellence and collaborates closely with cross-functional teams including Sales, Marketing, and Medical Affairs.
Headquarters
Redwood City, California, United States
Company Size
201-500 employees
Founded
2014
Revolution Medicines (RevMed) is a biopharmaceutical company dedicated to discovering, developing, and delivering novel targeted medicines for patients with cancer. Their mission focuses specifically on "revolutionizing treatment for patients with RAS‑addicted cancers" through precision-targeted therapies. The company emphasizes a science-driven, end-to-end approach from discovery to delivery. RevMed brands its team as "Revolutionaries" committed to transforming outcomes for people with RAS‑driven tumors.
Victory Capital Management Inc. Trims Stock Holdings in Revolution Medicines, Inc. $RVMD
13 hours ago
Revolution Medicines Trials, Funding Capacity And Insider Moves Shape Risk Outlook
5 days ago
Revolution Medicines Reports Fourth Quarter and Full Year 2025 Financial Results and Update on Corporate Progress
2 weeks ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Revolution Medicines.
Revolution Medicines didn’t post a salary, so this is our estimate from similar listings.
Revolution Medicines, Inc. (RVMD) Net Loss Widens amid Progress on Clinical Trial Programs
1 week ago
Associate Director, Market and Patient Access Training
Compass Pathways
Commercial Training Lead Germany
BeOne Medicines
Commercial Excellence Training Manager
Össur
Manager, Commercial Training Operations
Compass Pathways
Associate Director, Commercial Training, Europe
BeOne Medicines
Lead, Product Training
AstraZeneca